Similar articles for PMID: 24726728

Year	Number of Results
2006	1
2007	4
2008	6
2009	3
2010	10
2011	4
2012	7
2013	16
2014	16
2015	8
2016	16
2017	14
2018	7
2019	8
2020	5
2021	10
2022	7
2023	6
2024	0

1

Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks.

Li XL, Jones MF, Subramanian M, Lal A. Li XL, et al. FEBS Lett. 2014 Aug 19;588(16):2610-5. doi: 10.1016/j.febslet.2014.03.054. Epub 2014 Apr 12. FEBS Lett. 2014. PMID: 24726728 Free PMC article. Review.

2

A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis.

Subramanian M, Francis P, Bilke S, Li XL, Hara T, Lu X, Jones MF, Walker RL, Zhu Y, Pineda M, Lee C, Varanasi L, Yang Y, Martinez LA, Luo J, Ambs S, Sharma S, Wakefield LM, Meltzer PS, Lal A. Subramanian M, et al. Oncogene. 2015 Feb 26;34(9):1094-104. doi: 10.1038/onc.2014.46. Epub 2014 Mar 24. Oncogene. 2015. PMID: 24662829 Free PMC article.

3

Mutant p53-R273H gains new function in sustained activation of EGFR signaling via suppressing miR-27a expression.

Wang W, Cheng B, Miao L, Mei Y, Wu M. Wang W, et al. Cell Death Dis. 2013 Apr 4;4(4):e574. doi: 10.1038/cddis.2013.97. Cell Death Dis. 2013. PMID: 23559009 Free PMC article.

4

Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.

Dong P, Karaayvaz M, Jia N, Kaneuchi M, Hamada J, Watari H, Sudo S, Ju J, Sakuragi N. Dong P, et al. Oncogene. 2013 Jul 4;32(27):3286-95. doi: 10.1038/onc.2012.334. Epub 2012 Jul 30. Oncogene. 2013. PMID: 22847613 Free PMC article.

5

Friend or Foe: MicroRNAs in the p53 network.

Luo Z, Cui R, Tili E, Croce C. Luo Z, et al. Cancer Lett. 2018 Apr 10;419:96-102. doi: 10.1016/j.canlet.2018.01.013. Epub 2018 Jan 9. Cancer Lett. 2018. PMID: 29330109 Review.

6

Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.

Gunaratne PH, Pan Y, Rao AK, Lin C, Hernandez-Herrera A, Liang K, Rait AS, Venkatanarayan A, Benham AL, Rubab F, Kim SS, Rajapakshe K, Chan CK, Mangala LS, Lopez-Berestein G, Sood AK, Rowat AC, Coarfa C, Pirollo KF, Flores ER, Chang EH. Gunaratne PH, et al. Cancer. 2019 Jul 15;125(14):2409-2422. doi: 10.1002/cncr.32053. Epub 2019 Apr 23. Cancer. 2019. PMID: 31012964 Free PMC article.

7

Mutant p53 drives invasion in breast tumors through up-regulation of miR-155.

Neilsen PM, Noll JE, Mattiske S, Bracken CP, Gregory PA, Schulz RB, Lim SP, Kumar R, Suetani RJ, Goodall GJ, Callen DF. Neilsen PM, et al. Oncogene. 2013 Jun 13;32(24):2992-3000. doi: 10.1038/onc.2012.305. Epub 2012 Jul 16. Oncogene. 2013. PMID: 22797073

8

CD95 is part of a let-7/p53/miR-34 regulatory network.

Hau A, Ceppi P, Peter ME. Hau A, et al. PLoS One. 2012;7(11):e49636. doi: 10.1371/journal.pone.0049636. Epub 2012 Nov 14. PLoS One. 2012. PMID: 23166734 Free PMC article.

9

Conserved regulation of p53 network dosage by microRNA-125b occurs through evolving miRNA-target gene pairs.

Le MT, Shyh-Chang N, Khaw SL, Chin L, Teh C, Tay J, O'Day E, Korzh V, Yang H, Lal A, Lieberman J, Lodish HF, Lim B. Le MT, et al. PLoS Genet. 2011 Sep;7(9):e1002242. doi: 10.1371/journal.pgen.1002242. Epub 2011 Sep 15. PLoS Genet. 2011. PMID: 21935352 Free PMC article.

10

MicroRNA Control of p53.

Liu J, Zhang C, Zhao Y, Feng Z. Liu J, et al. J Cell Biochem. 2017 Jan;118(1):7-14. doi: 10.1002/jcb.25609. Epub 2016 Jun 3. J Cell Biochem. 2017. PMID: 27216701 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

131 results

Results by year